Skip to content

Gastro-intestinal permeability and intense physical activity (GRINTA)

Gastro-intestinal permeability and intense physical activity (GRINTA) - Gastro-intestinal permeability and intense physical activity (GRINTA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40654
Enrollment
15
Registered
2014-07-04
Start date
2014-09-19
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastro-intestinal permeabilty gut barrier function intestinal integrity

Interventions

Ingestion of multi sugar and glutamine- alanine solutions to evaluate gut function. 5 different exercise conditions as described in study design

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Male • Generally healthy • Recreational athlete with at least two years of cycling experience of at least twice a week • 18-35 years old • Meeting criteria of valid max-test • Body mass index (BMI) 20-25 kg/m2 • Veins suitable for blood sampling at inspection

Exclusion criteria

Exclusion criteria: • Known symptoms of immune diseases such as diabetes, celiac disease, gastric disease or cystic fibrosis • Known symptoms of intestinal diseases such as Crohn*s disease, ulcerosis, irritable bowel syndrome or cystic fibrosis • Smoking • Use of hard drugs • Use of specific medicines: o Chronic use of NSAIDs: aspirin, ibuprofen, etc. o Drugs for gastric and/or intestinal function • Participation in other scientific studies • Blood donation during the last six weeks prior to the start of the study

Design outcomes

Primary

MeasureTime frame
The main study parameters are the relative increase in intestinal permeability (lactulose/rhamnose ratio) and plasma levels of glutamine and glutamine-derived amino acids.

Secondary

MeasureTime frame
As secondary endpoints several markers of gastro-intestinal integrity and inflammation are studied in blood, urine and saliva.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)